Peripheral expression of ocular antigens in regulation and therapy of ocular autoimmunity

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

The retina is a well-known immune-privileged tissue in the eye. Gene therapy and transgenic strategies have been taken to explore the relationship between the immune system and retinal antigens. Retroviruses were used to express retina-specific antigens or fragments systemically, leading to an antigen-specific loss of susceptibility to autoimmune disease. Transgenic strategies used a neo self-antigen, β-galactosidase, or a known retinal antigen, interphotoreceptor retinoid-binding protein, to show that immune recognition of antigen by mice, which express solely in the retina, is not detectably different than that of mice that don't express this antigen. Together, these studies show that antigens expressed solely in the retina do not appear to be seen by the immune system, demonstrating that sequestration contributes to the lack of antigen recognition and absence of tolerance. Provision of these antigens outside of the retina provides the opportunity for development of peripheral tolerance, protection from autoimmunity, and potential therapies.

Original languageEnglish (US)
Pages (from-to)101-121
Number of pages21
JournalInternational Reviews of Immunology
Volume21
Issue number2-3
DOIs
StatePublished - Aug 1 2002

Fingerprint

Autoimmunity
Antigens
Retina
Therapeutics
Immune System
Galactosidases
Peripheral Tolerance
Autoantigens
Retroviridae
Genetic Therapy
Autoimmune Diseases

Keywords

  • Autoimmunity
  • Immune privilege
  • Retina
  • Self-antigens
  • T cells
  • Tolerance

Cite this

Peripheral expression of ocular antigens in regulation and therapy of ocular autoimmunity. / Gregerson, Dale S.

In: International Reviews of Immunology, Vol. 21, No. 2-3, 01.08.2002, p. 101-121.

Research output: Contribution to journalReview article

@article{961e80d615094bad9be5eddf753e8c98,
title = "Peripheral expression of ocular antigens in regulation and therapy of ocular autoimmunity",
abstract = "The retina is a well-known immune-privileged tissue in the eye. Gene therapy and transgenic strategies have been taken to explore the relationship between the immune system and retinal antigens. Retroviruses were used to express retina-specific antigens or fragments systemically, leading to an antigen-specific loss of susceptibility to autoimmune disease. Transgenic strategies used a neo self-antigen, β-galactosidase, or a known retinal antigen, interphotoreceptor retinoid-binding protein, to show that immune recognition of antigen by mice, which express solely in the retina, is not detectably different than that of mice that don't express this antigen. Together, these studies show that antigens expressed solely in the retina do not appear to be seen by the immune system, demonstrating that sequestration contributes to the lack of antigen recognition and absence of tolerance. Provision of these antigens outside of the retina provides the opportunity for development of peripheral tolerance, protection from autoimmunity, and potential therapies.",
keywords = "Autoimmunity, Immune privilege, Retina, Self-antigens, T cells, Tolerance",
author = "Gregerson, {Dale S}",
year = "2002",
month = "8",
day = "1",
doi = "10.1080/08830180212062",
language = "English (US)",
volume = "21",
pages = "101--121",
journal = "International Reviews of Immunology",
issn = "0883-0185",
publisher = "Informa Healthcare",
number = "2-3",

}

TY - JOUR

T1 - Peripheral expression of ocular antigens in regulation and therapy of ocular autoimmunity

AU - Gregerson, Dale S

PY - 2002/8/1

Y1 - 2002/8/1

N2 - The retina is a well-known immune-privileged tissue in the eye. Gene therapy and transgenic strategies have been taken to explore the relationship between the immune system and retinal antigens. Retroviruses were used to express retina-specific antigens or fragments systemically, leading to an antigen-specific loss of susceptibility to autoimmune disease. Transgenic strategies used a neo self-antigen, β-galactosidase, or a known retinal antigen, interphotoreceptor retinoid-binding protein, to show that immune recognition of antigen by mice, which express solely in the retina, is not detectably different than that of mice that don't express this antigen. Together, these studies show that antigens expressed solely in the retina do not appear to be seen by the immune system, demonstrating that sequestration contributes to the lack of antigen recognition and absence of tolerance. Provision of these antigens outside of the retina provides the opportunity for development of peripheral tolerance, protection from autoimmunity, and potential therapies.

AB - The retina is a well-known immune-privileged tissue in the eye. Gene therapy and transgenic strategies have been taken to explore the relationship between the immune system and retinal antigens. Retroviruses were used to express retina-specific antigens or fragments systemically, leading to an antigen-specific loss of susceptibility to autoimmune disease. Transgenic strategies used a neo self-antigen, β-galactosidase, or a known retinal antigen, interphotoreceptor retinoid-binding protein, to show that immune recognition of antigen by mice, which express solely in the retina, is not detectably different than that of mice that don't express this antigen. Together, these studies show that antigens expressed solely in the retina do not appear to be seen by the immune system, demonstrating that sequestration contributes to the lack of antigen recognition and absence of tolerance. Provision of these antigens outside of the retina provides the opportunity for development of peripheral tolerance, protection from autoimmunity, and potential therapies.

KW - Autoimmunity

KW - Immune privilege

KW - Retina

KW - Self-antigens

KW - T cells

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=2242493413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2242493413&partnerID=8YFLogxK

U2 - 10.1080/08830180212062

DO - 10.1080/08830180212062

M3 - Review article

C2 - 12424839

AN - SCOPUS:2242493413

VL - 21

SP - 101

EP - 121

JO - International Reviews of Immunology

JF - International Reviews of Immunology

SN - 0883-0185

IS - 2-3

ER -